Filana Therapeutics (FLNA) Change in Receivables (2011)

Filana Therapeutics (FLNA) posted Change in Receivables of -$640000.0 for Q4 2011, down 221.61% on a QoQ basis from -$199000.0 in Q3 2011.

Analysis

Filana Therapeutics (FLNA) Change in Receivables (2011) Analysis & Trends

Filana Therapeutics has reported Change in Receivables for 1 years, with the latest figure at -$640000.0 in Q4 2011.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	1.09 Bn
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	333.00 Mn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	140.20 Mn
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	838.50 Mn
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	-
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-53.00 Mn
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	31.60 Mn
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	269.40 Mn
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	-
10	Filana Therapeutics	38.14 Mn	38.14 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2011	-640,000.00
Sep 30, 2011	-199,000.00